Millene A. Honorato
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Millene A. Honorato has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Bruna M. Manzini
Laboratory of Hemostasis, Hemocentro-Unicamp, Universidade Estadual de Campinas, Campinas 13083-878, SP, Brazil
1 shared publication - Erich Vinicius De Paula
Universidade Estadual de Campinas (UNICAMP)
1 shared publication - Erik S. Braga
Laboratory of Biological Chemistry, Department of Organic Chemistry, Institute of Chemistry, Universidade Estadual de Campinas, Campinas 13083-862, SP, Brazil
1 shared publication - Fernanda Andrade Orsi
School of Medical Sciences, University of Campinas (UNICAMP), Campinas, Brazil
1 shared publication - Folorunsho Bright Omage
Computational Biology Research Group, Embrapa Digital Agriculture, Av. André Tosello 209, Campinas, São Paulo 13083-886, Brazil; Biological Chemistry Laboratory, Department of Organic Chemistry, Institute of Chemistry, University of Campinas (UNICAMP), R. Monteiro Lobato 270, Campinas, São Paulo 13083-970, Brazil
1 shared publication - Gabriela Goes Yamaguti-Hayakawa
Laboratory of Hemostasis, Hemocentro-Unicamp, Universidade Estadual de Campinas, Campinas 13083-878, SP, Brazil
1 shared publication
Latest Publications
- Open Access
Mapping Thrombosis Serum Markers by 1H-NMR Allied with Machine Learning Tools
Machine learning and artificial intelligence tools were used to investigate the discriminatory potential of blood serum metabolites for thromboembolism and antiphospholipid syndrome (APS). 1H-NMR-based metabonomics data of the serum samples of patients with arterial or venous thromboembolism (VTE) without APS (n = 32), thrombotic primary APS patients (APS, n = 32), and healthy controls (HCs) (n = 32) were investigated. Unique metabolic profiles between VTE and HCs, APS and HCs, and between VTE and triple-positive APS groups were indicative of the significant alterations in the metabolic pathways of glycolysis, the TCA cycle, lipid metabolism, and branched-chain amino acid (BCAA) metabolism, and pointed to the complex pathogenesis mechanisms of APS and VTE. Histidine, 3-hydroxybutyrate, and threonine were shown to be the top three metabolites with the most substantial impact on model predictions, suggesting that these metabolites play a pivotal role in distinguishing among APS, VTE, and HCs. These metabolites might be potential biomarkers to differentiate APS and VTE patients.
Open AccessMapping Thrombosis Serum Markers by 1H-NMR Allied with Machine Learning Tools
Machine learning and artificial intelligence tools were used to investigate the discriminatory potential of blood serum metabolites for thromboembolism and antiphospholipid syndrome (APS). 1H-NMR-based metabonomics data of the serum samples of patients with arterial or venous thromboembolism (VTE) without APS (n = 32), thrombotic primary APS patients (APS, n = 32), and healthy controls (HCs) (n = 32) were investigated. Unique metabolic profiles between VTE and HCs, APS and HCs, and between VTE and triple-positive APS groups were indicative of the significant alterations in the metabolic pathways of glycolysis, the TCA cycle, lipid metabolism, and branched-chain amino acid (BCAA) metabolism, and pointed to the complex pathogenesis mechanisms of APS and VTE. Histidine, 3-hydroxybutyrate, and threonine were shown to be the top three metabolites with the most substantial impact on model predictions, suggesting that these metabolites play a pivotal role in distinguishing among APS, VTE, and HCs. These metabolites might be potential biomarkers to differentiate APS and VTE patients.